Hypocomplementemic Urticarial Vasculitis Syndrome and Chronic Urticaria

By

Introduction

Urticaria, commonly known as hives, is a frequent dermatological condition characterized by transient wheals, itching, and sometimes angioedema. While most cases are benign and self-limited, certain forms of urticaria may signal a more complex underlying disease. Two clinically important conditions that present with persistent urticarial lesions are chronic urticaria (CU) and hypocomplementemic urticarial vasculitis syndrome (HUVS).

Although they may appear similar clinically, these disorders differ significantly in pathophysiology, diagnostic criteria, systemic involvement, and management. Proper differentiation is critical because HUVS represents a systemic autoimmune vasculitis with potentially serious organ involvement, whereas chronic urticaria is primarily a mast cell–mediated skin disorder.

Chronic Urticaria

Definition and Epidemiology

Chronic urticaria is defined as recurrent episodes of hives, angioedema, or both lasting more than six weeks. Symptoms often occur daily or intermittently and may persist for months or years. The condition affects approximately 0.5–1% of the population, with women affected more frequently than men.

Clinicians divide chronic urticaria into two main categories:

  1. Chronic Spontaneous Urticaria (CSU) – occurs without an identifiable trigger.

  2. Chronic Inducible Urticaria (CIndU) – triggered by specific physical stimuli such as cold, pressure, heat, sunlight, or vibration.

Most cases fall into the spontaneous category and are thought to involve autoimmune activation of mast cells.

Pathophysiology

Chronic urticaria is primarily a mast cell–mediated immune response. Mast cells in the skin release histamine and other inflammatory mediators such as leukotrienes and cytokines. This release causes:

  • Vasodilation

  • Increased vascular permeability

  • Dermal edema

  • Pruritus (itching)

In many patients, the immune system produces autoantibodies that activate mast cells, leading to chronic symptoms. This mechanism explains why many cases are classified as autoimmune chronic urticaria.

Clinical Features

Typical symptoms include:

  • Raised, red or skin-colored wheals

  • Intense itching

  • Lesions lasting less than 24 hours

  • Recurrence in different areas of the body

  • Angioedema (swelling of lips, eyelids, or extremities)

Unlike urticarial vasculitis, lesions usually do not leave bruising or hyperpigmentation.

Diagnostic Evaluation

Diagnosis of chronic urticaria is largely clinical, based on history and physical examination. Extensive allergy testing is usually unnecessary because classic IgE-mediated allergies rarely cause chronic symptoms.

Basic Laboratory Tests

Routine tests help identify underlying inflammation or associated conditions:

  • Complete Blood Count (CBC) with differential

  • Erythrocyte Sedimentation Rate (ESR)

  • C-reactive Protein (CRP)

  • Thyroid Function Tests (TSH and anti-TPO antibodies)

Autoimmune thyroid disease is frequently associated with chronic urticaria.

Specialized Diagnostic Tests

Autologous Serum Skin Test (ASST)
In this test, a patient's serum is injected into their own skin. A wheal response indicates the presence of autoantibodies activating mast cells.

Basophil Histamine Release Assay
A specialized laboratory test that detects autoimmune activation of basophils.

Skin Biopsy
Performed when lesions last longer than 24 hours or leave bruising to rule out urticarial vasculitis.

Monitoring Disease Activity

Clinicians often use standardized scoring tools:

  • Urticaria Activity Score (UAS7) – tracks daily severity of itch and number of hives.

  • Urticaria Control Test (UCT) – assesses symptom control and treatment effectiveness.

Treatment

Treatment follows a stepwise approach.

First-line therapy

  • Second-generation antihistamines

Second-line therapy

  • Increased antihistamine dosing

  • Leukotriene receptor antagonists

Advanced therapies

  • Omalizumab (anti-IgE monoclonal antibody)

  • Immunosuppressants such as cyclosporine for refractory cases

Most patients eventually experience remission within several years.

Hypocomplementemic Urticarial Vasculitis Syndrome (HUVS)

Definition

Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare autoimmune disorder characterized by chronic urticaria associated with low complement levels and systemic vasculitis affecting small blood vessels.

Unlike chronic urticaria, HUVS is a vasculitic disease that may involve multiple organs.

Pathophysiology

HUVS results from immune complex deposition in small blood vessels. These complexes activate the complement system, leading to:

  • Inflammation of blood vessels

  • Consumption of complement proteins

  • Persistent hypocomplementemia

A key immunologic marker of the disease is the presence of anti-C1q antibodies, which play a central role in disease development.

Clinical Manifestations

Patients with HUVS typically present with urticarial lesions that differ from those seen in chronic urticaria.

Skin manifestations

  • Painful or burning urticarial lesions

  • Wheals lasting more than 24 hours

  • Possible bruising or hyperpigmentation after resolution

Systemic symptoms

HUVS frequently involves multiple organs, including:

  • Arthritis or joint pain

  • Angioedema

  • Abdominal pain

  • Eye inflammation

  • Kidney disease (glomerulonephritis)

  • Pulmonary disease, including severe chronic obstructive pulmonary disease (COPD)

Pulmonary involvement represents one of the most serious complications.

Diagnostic Criteria

HUVS is diagnosed using the Schwarz criteria, which require:

Major criteria

  1. Chronic urticaria lasting longer than six months

  2. Hypocomplementemia

Minor criteria (two required)

  • Leukocytoclastic vasculitis on skin biopsy

  • Arthritis or arthralgia

  • Glomerulonephritis

  • Ocular inflammation

  • Presence of anti-C1q antibodies

Diagnostic Tests

Skin Biopsy

A biopsy from a lesion less than 48 hours old typically shows leukocytoclastic vasculitis, characterized by neutrophilic infiltration and damaged vessel walls.

Complement Testing

Laboratory findings include decreased levels of:

  • C1q

  • C3

  • C4

Low C1q levels are particularly characteristic of HUVS.

Autoantibody Testing

Anti-C1q antibodies are present in nearly all cases.

Inflammatory Markers

Elevated ESR and CRP indicate systemic inflammation.

Organ Function Tests

Because systemic involvement is common, evaluation may include:

  • Urinalysis or kidney biopsy for glomerulonephritis

  • Pulmonary function tests

  • Chest imaging

Differential Diagnosis

Several conditions can resemble HUVS and must be excluded:

  • Systemic lupus erythematosus (SLE)

  • Cryoglobulinemia

  • Hepatitis B or C infection

Approximately half of HUVS patients may eventually develop SLE, making long-term monitoring essential.

Treatment

Treatment depends on disease severity and organ involvement.

Mild disease

  • Antihistamines

  • Nonsteroidal anti-inflammatory drugs (NSAIDs)

  • Colchicine

Moderate to severe disease

  • Corticosteroids (prednisone)

  • Immunosuppressive medications such as azathioprine or cyclophosphamide

In severe systemic disease, aggressive immunosuppression may be necessary. 

Why Routine Allergy Tests Aren't Recommended

Chronic spontaneous urticaria is rarely caused by a classic, immediate (IgE-mediated) allergy. Therefore, typical IgE skin prick tests are generally not needed unless the history suggests a specific food or environmental trigger.

Feature

Chronic Urticaria

HUVS

Cause

Mast cell activation

Immune complex vasculitis

Lesion duration

<24 hours

>24 hours

Complement levels

Normal

Low

Skin biopsy

No vasculitis

Leukocytoclastic vasculitis

Systemic involvement

Rare

Common

Key antibody

Often none

Anti-C1q antibodies

Clinical Importance

Urticarial vasculitis is believed to be underdiagnosed, particularly when patients initially present with chronic hives. Persistent lesions lasting longer than 24 hours, pain rather than itching, residual bruising, or systemic symptoms should prompt evaluation for vasculitis.

Early diagnosis of HUVS is crucial because organ involvement—especially lung disease—can significantly impact long-term outcomes.

Conclusion

Although chronic urticaria and hypocomplementemic urticarial vasculitis syndrome may initially appear similar, they represent fundamentally different diseases. Chronic urticaria is a mast cell–driven skin condition with generally benign prognosis, whereas HUVS is a systemic autoimmune vasculitis with potentially serious complications.

Accurate diagnosis requires careful evaluation of clinical features, laboratory findings, and histopathology. Recognizing the distinguishing features—particularly persistent lesions, hypocomplementemia, and systemic involvement—allows clinicians to initiate appropriate treatment and improve patient outcomes.

References:

Hypocomplementemic Urticarial Vasculitis Syndrome or Systemic Lupus Erythematosus in Evolution? https://pmc.ncbi.nlm.nih.gov/articles/PMC9033644/

Urticarial vasculitis and acquired autoinflammatory disorders https://www.pcds.org.uk/clinical-guidance/urticarial-vasculitis

Urticarial Vasculitis: A Retrospective Study of 15 Cases
https://actasdermo.org/en-urticarial-vasculitis-a-retrospective-study-articulo-resumen-S1578219013001455

Chronic Urticaria
https://www.ncbi.nlm.nih.gov/books/NBK555910/

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9 

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more